Compound News and Research

RSS

Bogotá’s strictest COVID restrictions delivered the clearest air-quality gains

A natural quasi-experiment in Suba, Bogotá, found that more stringent COVID-19 mobility restrictions were associated with larger reductions in PM₁₀ and PM₂.₅ air pollution. The findings suggest targeted traffic and emissions controls could improve urban air quality, although ozone responses were more complex, and the results may not generalize beyond this high-traffic district.

21 Jun 2026

PMOS rethink reframes a common hormone disorder as a whole-body disease

A new review reframes PCOS, now proposed as PMOS, as a systemic endocrine and metabolic disorder shaped by genetic, epigenetic, ovarian, metabolic, and neuroendocrine pathways. It highlights why inconsistent diagnosis and symptom-focused care have limited progress, while targeted therapies, biomarkers, machine learning, and organ-on-chip models may support more personalized treatment.

18 Jun 2026

Deep learning identifies novel compounds against antibiotic-resistant gonorrhea

With tens of millions of annual cases, gonorrhea is the second most frequently reported sexually transmitted infection (STI). Alone in the U.S., over 600,000 cases are reported each year.

17 Jun 2026

New study uncovers how prostate cancer cells evade treatment

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.

16 Jun 2026

Purdue develops next-generation platform to accelerate cancer drug discovery

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to dramatically accelerate one of the slowest and most challenging stages of cancer drug discovery: identifying promising compounds that could eventually become new therapies.

16 Jun 2026

Study maps biological pathways of weed killer during pregnancy

Exposure to glyphosate, the active ingredient in many weed killers, was linked to changes in several hormones that support pregnancy and fetal development-in one of the few studies to examine how a widely used herbicide may affect the body during pregnancy. The results come from a new study led by University of Michigan School of Public Health researchers.

16 Jun 2026

Lab trials prove copper therapy enhances cognitive function and spatial learning

Monash University researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly reduces toxic Alzheimer's proteins and improves long-term spatial memory.

15 Jun 2026

Novel metal-free prodrug suppresses cancer spread in preclinical models

A carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine.

12 Jun 2026

Self-help program improves mental health among displaced refugees

A simple self-help workbook paired with brief phone support can make a measurable difference to the mental health of displaced refugees, a new study has found.

11 Jun 2026

Gut bacterial molecule reduces intestinal inflammation by slowing cell energy

Enterobactin, a molecule produced by gut bacteria, may hold a surprising key to reducing intestinal inflammation. Not by attacking the immune system directly, but by temporarily slowing down the cell's own energy production.

11 Jun 2026

Automated self-driving labs accelerate the search for new medicines

The Acceleration Consortium (AC) at the University of Toronto and the Structural Genomics Consortium (SGC) announced today a formalized partnership to help tackle a persistent challenge in biomedicine and early drug discovery: the development of bioactive molecules with drug-like properties, advancing our understanding of human health and disease and jump-starting new drug discovery programs.

10 Jun 2026

Realistic cellular conditions revive previously dismissed drug candidates

A drug once dismissed as ineffective suddenly worked - when scientists tested it under more realistic conditions that mimic the human body.

9 Jun 2026

Extreme heat disrupts treatment and daily routines for cancer patients

New research published in the journal Environmental Research: Climate found that extreme heat is already influencing how people with cancer manage daily life, access care, and make treatment-related decisions.

9 Jun 2026

Fathers shape childhood obesity risk long before birth

New research highlights fathers' influence on childhood obesity risk through sperm changes, lifestyle, and parenting, urging inclusive prevention strategies.

9 Jun 2026

Study identifies new therapeutic candidate for KRAS-driven pancreatic cancer

A new research paper was published in Volume 17 of Oncotarget on June 3, 2026, titled "The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation."

8 Jun 2026

Father's alcohol use before conception impacts offspring development

A growing body of research suggests that a father's health before conception may play a larger role in child development than previously understood - and researchers are working to understand how a father's drinking before conception may affect offspring health and development.

8 Jun 2026

Researchers develop compound 10 to slow Alzheimer's disease progression

Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-aging effects.

8 Jun 2026

Revolutionizing calibration: How Lumo uses machine learning to streamline E&L screening and toxicological risk assessment

Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.

From Jordi Labs 5 Jun 2026

New topical gel uses repurposed MS drug to heal burns

Researchers at the Terasaki Institute for Biomedical Innovation and the University of Arizona College of Medicine have developed a topical gel formulation with 4-aminopyridine (4-AP), to treat burn wounds, achieving near-complete closure in 21 days.

4 Jun 2026